Invesco Mutual Fund Substantial Acquisition Reporting in Global Health Limited Equity

Invesco Asset Management (India) Private Limited has reported a substantial acquisition concerning various schemes under Invesco Mutual Fund in the equity shares of Global Health Limited (“the Company”). As of the close of business on February 20, 2026, the aggregate holding reached 5.0273% of the total paid-up share capital. This disclosure adheres to regulatory requirements concerning Substantial Acquisition of Shares & Takeovers, detailing the acquisition details in Annexure 1.

Disclosure of Aggregate Shareholding Increase

Invesco Asset Management (India) Pvt. Ltd., acting as the Investment Manager for Invesco Mutual Fund, officially communicated an increase in its holding in Global Health Limited (“the Company”). This disclosure, dated February 23, 2026, confirms compliance with mandated reporting standards for Substantial Acquisition of Shares.

Holding Status as of February 20, 2026

The total aggregate holding across all relevant Invesco Mutual Fund schemes in the equity shares of Global Health Limited stood at 5.0273% of the paid-up share capital as of the close of business on February 20, 2026.

Details of Acquisition (Annexure 1 Summary)

The document details the transaction, noting that the acquisition was executed via the Open Market route.

Holding Before Acquisition:

  • Shares carrying voting rights: 1,25,11,138 shares, representing 4.6546% of the total share capital.
  • Total holding (a+b+c+d): 1,25,11,138 shares.

Details of Acquisition:

  • Shares carrying voting rights acquired: 10,01,873 shares.
  • Percentage acquired: 0.3727% of the total share capital.

Holding After Acquisition:

Following the acquisition on February 20, 2026:

  • The acquirer’s total holding amounts to 1,35,13,011 shares carrying voting rights.
  • This new aggregate holding represents 5.0273% of the total share capital of Global Health Limited.

Capital Structure Confirmation

The equity share capital/total voting capital of Global Health Limited remained unchanged before and after the acquisition. The capital base stood at Rs. 53,75,80,764/-, comprising 26,87,90,382 equity shares of Re. 2/- each.

The disclosure was formally submitted by Hardik Mehta, Chief Risk Officer for Invesco Asset Management (India) Pvt. Ltd., on February 23, 2026.

Source: BSE

Previous Article

Himadri Speciality Chemical Subsidiary Name Change Effective February 23, 2026

Next Article

Mazagon Dock Shipbuilders Ltd. Non-Official Independent Director Cessation